CQS Cayman
ONCE

CQS Cayman’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

CQS Cayman’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-134,669
Closed -$6.89M – 150
2016
Q2 		$6.89M Buy
+134,669
New +$5.75M 0.61% 43

Other funds holding ONCE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

CQS Cayman's ONCE Position: Q3 2016 in Review

CQS Cayman sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q3 2016, closing a stake of 134,669 shares — an estimated $6.89M sold.

CQS Cayman first reported a position in ONCE in Q2 2016 and held it in 1 quarter. The position peaked at $6.89M in Q2 2016. 121 funds tracked by Wall St. Rank hold ONCE as of Q3 2016.

  • CQS Cayman reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
  • CQS Cayman sold 134,669 Spark Therapeutics, Inc. Common Stock shares in Q3 2016, an estimated $6.89M.
  • CQS Cayman first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2016 and held it in 1 quarter.
  • CQS Cayman's Spark Therapeutics, Inc. Common Stock position peaked at $6.89M in Q2 2016.
  • 121 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2016.

Based on CQS Cayman's 13F filing for Q3 2016, filed 14 Nov 2016.